Skip to content
MHRA designated as WHO-Listed Authority: a milestone for UK life sciences and global health. 

MHRA designated as WHO-Listed Authority: a milestone for UK life sciences and global health. 

WHO recognition affirms MHRA’s commitment to regulatory excellence, innovation and global collaboration. The Medicines and Healthcare products Regulat…

Read More
Open letter to the global pharmaceutical and biopharmaceutical industry

Open letter to the global pharmaceutical and biopharmaceutical industry

Open letter to the global pharmaceutical and biopharmaceutical industry, We are writing on behalf of the UK Medicines and Healthcare products Regulato…

Read More
botulism following adverse reactions to cosmetic procedures involving botulinum toxin.

UKHSA issues warning over botulism.

UKHSA warns public to be alert to botulism following adverse reactions to cosmetic procedures involving botulinum toxin. UK Health Security Agency (UK…

Read More
First major overhaul of medical device regulation comes into force across Great Britain.

First major overhaul of medical device regulation comes into force across Great Britain.

New Post-Market Surveillance (PMS) regulations have taken effect across Great Britain, requiring medical device manufacturers to proactively monitor t…

Read More

Contact Us

info@christagdppharma.com

Milton Keynes, Buckinghamshire

Office Hours

Monday to Friday 9:00 am – 6:00 pm

Follow on Social